Galam Leem

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Early prediction of liver metastasis in pancreatic cancer using routine clinical data: an externally validated machine learning model.

Early prediction of liver metastasis in pancreatic cancer using routine clinical data: an externally validated machine learning model.

Journal: BMC cancer

Published: August 12, 2025

Comparison of second-line chemotherapy regimens in advanced biliary tract cancer: a systematic review, meta-analysis, and population-based cohort study.

Comparison of second-line chemotherapy regimens in advanced biliary tract cancer: a systematic review, meta-analysis, and population-based cohort study.

Journal: International journal of surgery (London, England)

Published: May 08, 2025

Remimazolam Preserves Oxygen Reserve and Improves Sedation Safety Compared to Propofol in Endoscopic Retrograde Cholangiopancreatography.

Remimazolam Preserves Oxygen Reserve and Improves Sedation Safety Compared to Propofol in Endoscopic Retrograde Cholangiopancreatography.

Journal: United European gastroenterology journal

Published: May 02, 2025

SpyGlass Direct Visualization System: A Cost-Effective Approach Enhancing Nutritional and Immune Recovery in Difficult Bile Duct Stone Management.

SpyGlass Direct Visualization System: A Cost-Effective Approach Enhancing Nutritional and Immune Recovery in Difficult Bile Duct Stone Management.

Journal: Yonsei medical journal

Published: March 05, 2025

Fatal air embolism during intestinal endoscopy in Kasai portoenterostomy for biliary atresia: A case report.

Fatal air embolism during intestinal endoscopy in Kasai portoenterostomy for biliary atresia: A case report.

Journal: World journal of gastrointestinal endoscopy

Published: February 07, 2025

Establishing 3D organoid models from patient-derived conditionally reprogrammed cells to bridge preclinical and clinical insights in pancreatic cancer.

Establishing 3D organoid models from patient-derived conditionally reprogrammed cells to bridge preclinical and clinical insights in pancreatic cancer.

Journal: Molecular cancer

Published: January 14, 2025

Long-Term Outcomes of Neoadjuvant Therapy Versus Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma.

Long-Term Outcomes of Neoadjuvant Therapy Versus Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma.

Journal: Cancer medicine

Published: February 26, 2024

Uncovering the clinicopathological features of early recurrence after surgical resection of pancreatic cancer.

Uncovering the clinicopathological features of early recurrence after surgical resection of pancreatic cancer.

Journal: Scientific reports

Published: September 19, 2023

Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study.

Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study.

Journal: Frontiers in oncology

Published: April 15, 2023

Randomized Trial of Prophylactic Antibiotics for Endoscopic Retrograde Cholangiopancreatography in Patients With Biliary Obstruction.

Randomized Trial of Prophylactic Antibiotics for Endoscopic Retrograde Cholangiopancreatography in Patients With Biliary Obstruction.

Journal: The American journal of gastroenterology

Published: March 09, 2023

Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis.

Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis.

Journal: Genome medicine

Published: October 12, 2022

Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy-Refractory Biliary Tract Cancer: A Multicenter Open-Label Phase 1/2a Trial.

Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy-Refractory Biliary Tract Cancer: A Multicenter Open-Label Phase 1/2a Trial.

Journal: Cancers

Published: August 07, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026